Search research articles
Contact Us
Filters
Showing results (71-80 of 207) with videos related to
Page
of 21
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 15, 2019
Radiation Dosimetry and Biodistribution of <sup>68</sup>Ga-FAPI-46 PET Imaging in Cancer Patients
Catherine Meyer, Magnus Dahlbom, Thomas Lindner, et al.
Cancer Treatment Reviews
|
March 18, 2023
Incorporating radioligand therapy in clinical practice in the United States for patients with prostate cancer
Jeremie Calais, Stephen M Eulau, Linda Gardner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 3, 2024
Best Patient Care Practices for Administering PSMA-Targeted Radiopharmaceutical Therapy
Jeremie Calais, Michael J Morris, Ayse Tuba Kendi, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 12, 2020
<sup>68</sup>Ga-FAPi-46 diffuse bilateral breast uptake in a patient with cervical cancer after hormonal stimulation
Ida Sonni, Stephanie Lee-Felker, Sanaz Memarzadeh, et al.
EJNMMI Research
|
December 4, 2019
Evaluation of SUV normalized by lean body mass (SUL) in <sup>68</sup>Ga-PSMA11 PET/CT: a bi-centric analysis
Andrei Gafita, Jeremie Calais, Charlott Franz, et al.
Clinical Nuclear Medicine
|
July 24, 2020
Incidental Detection of Elastofibroma Dorsi With 68Ga-FAPI-46 and 18F-FDG PET/CT in a Patient With Esophageal Cancer
Artineh Hayrapetian, Mark D Girgis, Jane Yanagawa, et al.
Seminars in Nuclear Medicine
|
April 22, 2026
The Role of FAPI PET/CT in the Assessment of Inflammatory Diseases
Elnaz Jenabi, Masatoshi Hotta, Armin Atzinger, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 21, 2021
High <sup>68</sup> Ga-FAPI-46 uptake in a pulmonary necrotizing granuloma in a patient with subcutaneous lipoma
Masatoshi Hotta, Matthias R Benz, Martin S Allen-Auerbach, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 7, 2023
Prognostic Value of End-of-Treatment PSMA PET/CT in Patients Treated with <sup>177</sup>Lu-PSMA Radioligand Therapy: A Retrospective, Single-Center Analysis
Vishnu Murthy, Andrei Gafita, Pan Thin, et al.
The Lancet. Oncology
|
November 2, 2019
What is the best PET target for early biochemical recurrence of prostate cancer?-Authors' reply
Jeremie Calais, Francesco Ceci, Matthias Eiber, et al.
Page
of 21
Search research articles
Search
Showing results (71-80 of 207) with videos related to
Sort By:
Page
of 21
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 15, 2019
Radiation Dosimetry and Biodistribution of <sup>68</sup>Ga-FAPI-46 PET Imaging in Cancer Patients
Catherine Meyer, Magnus Dahlbom, Thomas Lindner, et al.
Cancer Treatment Reviews
|
March 18, 2023
Incorporating radioligand therapy in clinical practice in the United States for patients with prostate cancer
Jeremie Calais, Stephen M Eulau, Linda Gardner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 3, 2024
Best Patient Care Practices for Administering PSMA-Targeted Radiopharmaceutical Therapy
Jeremie Calais, Michael J Morris, Ayse Tuba Kendi, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 12, 2020
<sup>68</sup>Ga-FAPi-46 diffuse bilateral breast uptake in a patient with cervical cancer after hormonal stimulation
Ida Sonni, Stephanie Lee-Felker, Sanaz Memarzadeh, et al.
EJNMMI Research
|
December 4, 2019
Evaluation of SUV normalized by lean body mass (SUL) in <sup>68</sup>Ga-PSMA11 PET/CT: a bi-centric analysis
Andrei Gafita, Jeremie Calais, Charlott Franz, et al.
Clinical Nuclear Medicine
|
July 24, 2020
Incidental Detection of Elastofibroma Dorsi With 68Ga-FAPI-46 and 18F-FDG PET/CT in a Patient With Esophageal Cancer
Artineh Hayrapetian, Mark D Girgis, Jane Yanagawa, et al.
Seminars in Nuclear Medicine
|
April 22, 2026
The Role of FAPI PET/CT in the Assessment of Inflammatory Diseases
Elnaz Jenabi, Masatoshi Hotta, Armin Atzinger, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 21, 2021
High <sup>68</sup> Ga-FAPI-46 uptake in a pulmonary necrotizing granuloma in a patient with subcutaneous lipoma
Masatoshi Hotta, Matthias R Benz, Martin S Allen-Auerbach, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 7, 2023
Prognostic Value of End-of-Treatment PSMA PET/CT in Patients Treated with <sup>177</sup>Lu-PSMA Radioligand Therapy: A Retrospective, Single-Center Analysis
Vishnu Murthy, Andrei Gafita, Pan Thin, et al.
The Lancet. Oncology
|
November 2, 2019
What is the best PET target for early biochemical recurrence of prostate cancer?-Authors' reply
Jeremie Calais, Francesco Ceci, Matthias Eiber, et al.
Page
of 21